101 related articles for article (PubMed ID: 29033184)
1. Over expression of HIF1α is associated with inactivation of both LimD1 and VHL in renal cell carcinoma: Clinical importance.
Sur S; Maurya AK; Roy A; Sharp TV; Pal DK; Panda CK
Pathol Res Pract; 2017 Dec; 213(12):1477-1481. PubMed ID: 29033184
[TBL] [Abstract][Full Text] [Related]
2. High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.
Basu M; Chatterjee A; Chakraborty B; Chatterjee E; Ghosh S; Samadder S; Pal DK; Roy A; Chakrabarti J; Ghosh A; Panda CK
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2309-2322. PubMed ID: 34080067
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
[TBL] [Abstract][Full Text] [Related]
4. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
Foxler DE; Bridge KS; James V; Webb TM; Mee M; Wong SC; Feng Y; Constantin-Teodosiu D; Petursdottir TE; Bjornsson J; Ingvarsson S; Ratcliffe PJ; Longmore GD; Sharp TV
Nat Cell Biol; 2012 Jan; 14(2):201-8. PubMed ID: 22286099
[TBL] [Abstract][Full Text] [Related]
5. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
[TBL] [Abstract][Full Text] [Related]
6. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
[TBL] [Abstract][Full Text] [Related]
7. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
[TBL] [Abstract][Full Text] [Related]
8. RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect.
Zhang CS; Liu Q; Li M; Lin SY; Peng Y; Wu D; Li TY; Fu Q; Jia W; Wang X; Ma T; Zong Y; Cui J; Pu C; Lian G; Guo H; Ye Z; Lin SC
Cell Res; 2015 Sep; 25(9):1025-42. PubMed ID: 26215701
[TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.
Damjanovic SS; Ilic BB; Beleslin Cokic BB; Antic JA; Bankovic JZ; Milicevic IT; Rodic GS; Ilic DS; Todorovic VN; Puskas N; Tulic CD
Exp Mol Pathol; 2016 Dec; 101(3):323-331. PubMed ID: 27845047
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas.
Pantuck AJ; An J; Liu H; Rettig MB
Cancer Res; 2010 Jan; 70(2):752-61. PubMed ID: 20068166
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
12. A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.
Foxler DE; Bridge KS; Foster JG; Grevitt P; Curry S; Shah KM; Davidson KM; Nagano A; Gadaleta E; Rhys HI; Kennedy PT; Hermida MA; Chang TY; Shaw PE; Reynolds LE; McKay TR; Wang HW; Ribeiro PS; Plevin MJ; Lagos D; Lemoine NR; Rajan P; Graham TA; Chelala C; Hodivala-Dilke KM; Spendlove I; Sharp TV
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29930174
[TBL] [Abstract][Full Text] [Related]
13. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
15. Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.
Leisz S; Schulz K; Erb S; Oefner P; Dettmer K; Mougiakakos D; Wang E; Marincola FM; Stehle F; Seliger B
Oncotarget; 2015 May; 6(13):11395-406. PubMed ID: 25890500
[TBL] [Abstract][Full Text] [Related]
16. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk.
Wei H; Ke HL; Lin J; Shete S; Wood CG; Hildebrandt MA
Mol Carcinog; 2014 Jan; 53(1):1-7. PubMed ID: 22517515
[TBL] [Abstract][Full Text] [Related]
18. Concomitant deregulation of HIF1alpha and cell cycle proteins in VHL-mutated renal cell carcinomas.
Atkins DJ; Gingert C; Justenhoven C; Schmahl GE; Bonato MS; Brauch H; Störkel S
Virchows Arch; 2005 Sep; 447(3):634-42. PubMed ID: 15991006
[TBL] [Abstract][Full Text] [Related]
19. REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma.
Singh A; Cheng D; Swaminathan J; Yang Y; Zheng Y; Gordon N; Gopalakrishnan V
Sci Rep; 2024 Jun; 14(1):13596. PubMed ID: 38866867
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]